NCT03925402View on ClinicalTrials.gov

Ertapenem for Initial Empirical Treatment of Third Generation Cephalosporin Resistant Enterobacteriaceae Bacteremia

CompletedOBSERVATIONAL

Enrollment

427

Participants

Timeline

Start Date

May 15, 2019

Primary Completion Date

December 31, 2021

Study Completion Date

October 1, 2022

Conditions

BacteremiaInfection, Bacterial

Interventions

DRUG

Ertapenem

Ertapenem injection

DRUG

Carbapenems

Other carbapenems injection

Trial Locations (1)

10400

Phramongkutklao Hospital, Bangkok

All Listed Sponsors

lead

Phramongkutklao College of Medicine and Hospital

OTHER

NCT03925402 - Ertapenem for Initial Empirical Treatment of Third Generation Cephalosporin Resistant Enterobacteriaceae Bacteremia | Biotech Hunter | Biotech Hunter